“According to a new report published by Introspective Market Research, Preeclampsia Diagnostics Market by Test Type, End User, and Region, The Global Preeclampsia Diagnostics Market Size Was Valued at USD 1.1 Billion in 2023 and is Projected to Reach USD 1.4 Billion by 2032, Growing at a CAGR of 2.7% from 2024–2032.”

The Preeclampsia Diagnostics Market plays a critical role in maternal healthcare by enabling the early detection and monitoring of preeclampsia, a potentially life-threatening pregnancy complication characterized by high blood pressure and organ dysfunction. Diagnostic solutions include blood pressure monitoring, urine protein tests, biomarker-based assays, and advanced imaging tools that assist clinicians in timely clinical decision-making.

Growing awareness regarding maternal mortality, increasing prenatal screening programs, and advancements in diagnostic technologies are driving market expansion. Hospitals, diagnostic laboratories, and maternity clinics increasingly rely on accurate and early diagnostic tools to improve pregnancy outcomes. Additionally, the integration of biomarker-based testing and point-of-care diagnostics is enhancing detection accuracy, especially in high-risk pregnancies.

Market Segmentation

The Preeclampsia Diagnostics Market is segmented into Test Type, End User, and Region.
By Test Type, the market is categorized into Blood Pressure Monitoring, Urine Protein Tests, Blood Tests, and Imaging Tests.
By End User, the market is categorized into Hospitals, Diagnostic Laboratories, and Maternity Clinics.
By Region, the market is categorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Growth Driver

The primary growth driver of the Preeclampsia Diagnostics Market is the rising global incidence of hypertensive disorders during pregnancy. Increasing maternal age, obesity, diabetes, and lifestyle-related risk factors have significantly elevated the prevalence of preeclampsia worldwide. Governments and healthcare organizations are prioritizing early prenatal screening to reduce maternal and neonatal mortality, thereby boosting demand for reliable diagnostic solutions. Additionally, growing investments in maternal healthcare infrastructure and routine antenatal testing protocols further support sustained market growth.

Market Opportunity

A key market opportunity lies in the development of advanced biomarker-based and point-of-care diagnostic tests. Innovations such as placental growth factor (PlGF) testing and rapid blood assays enable early risk prediction and real-time monitoring, especially in low-resource settings. Emerging economies present strong growth potential due to improving healthcare access, rising awareness of maternal health, and increasing adoption of affordable diagnostic technologies. Strategic collaborations between diagnostic manufacturers and healthcare providers are expected to accelerate market penetration globally.

Detailed Segmentation

Preeclampsia Diagnostics Market, Segmentation

The Preeclampsia Diagnostics Market is segmented on the basis of Test Type, End User, and Region.

Test Type

The Test Type segment is further classified into Blood Pressure Monitoring, Urine Protein Tests, and Blood Tests. Among these, the Blood Pressure Monitoring sub-segment accounted for the highest market share in 2023. Blood pressure monitoring remains the first-line diagnostic approach for preeclampsia detection due to its simplicity, cost-effectiveness, and routine use in prenatal care. Continuous technological improvements in digital and wearable blood pressure devices are enhancing accuracy and patient compliance, contributing to sustained dominance of this segment.

End User

The End User segment is further classified into Hospitals, Diagnostic Laboratories, and Maternity Clinics. Among these, the Hospitals sub-segment accounted for the highest market share in 2023. Hospitals serve as primary centers for high-risk pregnancy management, offering comprehensive diagnostic and monitoring services. The availability of advanced testing facilities, skilled healthcare professionals, and emergency care capabilities positions hospitals as the leading end users of preeclampsia diagnostic solutions.

Some of The Leading/Active Market Players Are-

• Roche Diagnostics (Switzerland)
• Siemens Healthineers (Germany)
• Thermo Fisher Scientific (USA)
• Abbott Laboratories (USA)
• Danaher Corporation (USA)
• PerkinElmer Inc. (USA)
• QuidelOrtho Corporation (USA)
• Bio-Rad Laboratories (USA)
• Sysmex Corporation (Japan)
• Fujirebio (Japan)
• Randox Laboratories (UK)
• DiaSorin S.p.A. (Italy)
• Agilent Technologies (USA)
• EKF Diagnostics (UK)
• Roche Diagnostics International Ltd. (Switzerland)
and other active players.

Key Industry Developments

In March 2024, a leading diagnostics company launched an advanced biomarker-based blood test designed to improve early detection of preeclampsia risk.
This innovation enables clinicians to identify high-risk pregnancies earlier, improving clinical intervention timelines and reducing adverse maternal outcomes.

In October 2023, a major healthcare provider expanded its maternal diagnostics portfolio through a strategic partnership with a diagnostic technology firm.
The collaboration aims to enhance access to point-of-care preeclampsia testing in emerging markets, supporting improved prenatal care delivery.

Key Findings of the Study

• Blood pressure monitoring remains the dominant test type segment
• Hospitals are the leading end-use segment globally
• North America holds the largest regional market share
• Rising maternal health awareness is a key growth driver
• Biomarker-based diagnostics are an emerging market trend

More Info:- https://introspectivemarketresearch.com/reports/preeclampsia-diagnostics-market/

About Us

At Introspective Market Research Private Limited, we are a forward-thinking research consulting firm committed to driving growth in the Preeclampsia Diagnostics Market. With deep insights, strategic solutions, and holistic research, we empower businesses to achieve success and dominance in the global Preeclampsia Diagnostics industry.

📞 Contact Us
Introspective Market Research Pvt. Ltd.
Phone: +91-91753-37569
Email: sales@introspectivemarketresearch.com
Web: www.introspectivemarketresearch.com